Skip to main content

View full-text article in PMC

. 2015 Oct 27;49(4):971–990. doi: 10.3233/JAD-150538

Table 2.

Change from baseline in physiological measures

		Week 6		Week 12
Endpoint	Baseline Score	change from baseline	p value (between groups)	change from baseline	p value (between groups)	Total Treatment p value
Physiological
Mg^2 + Urine (mg/ml)
MMFS-01	0.061 ± 0.003	0.026 ± 0.007	0.140	0.025 ± 0.007	0.048^*	0.027^*
Placebo	0.062 ± 0.006	0.012 ± 0.006	0.140	0.005 ± 0.007	0.048^*
[Mg^2 +] Plasma (mg/dL)
MMFS-01	2.04 ± 0.033	0.100 ± 0.032	0.026^*	0.065 ± 0.030	0.808	0.119
Placebo	2.06 ± 0.041	–0.002 ± 0.043	0.026^*	0.052 ± 0.035	0.808
[Mg^2 +]_i RBC (mg/10¹¹ cells)
MMFS-01	1.15 ± 0.038	0.003 ± 0.026	0.217	0.032 ± 0.023	0.262	0.829
Placebo	1.19 ± 0.035	0.049 ± 0.026	0.217	–0.009 ± 0.021	0.262

Mean ± SEM. ^*significant p < 0.05.